Back to News
Market Impact: 0.3
Artelo Biosciences Consensus Price Target Increased 2,600% to $826.20
Source: Nasdaq
Analyst EstimatesHealthcare & Biotech
The average one-year analyst price target for Artelo Biosciences was revised to $826.20 per share, up 2,600% from the prior $30.60 estimate dated September 10, 2025. The report provides no further context in the available text about the revision or its basis.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.35
Ticker Sentiment
ARTL0.60
More News
- Coinbase has been battered over the past month. Morgan Stanley says steer clear
- Kimberly-Clark closes its acquisition of Tylenol maker Kenvue. What to expect next
- Why is Apple stock falling afterhours today?
- RA Capital Management sells $9.13M in Lenz Therapeutics shares
- Karyopharm stock rating cut to neutral by Rodman on bankruptcy
- Vornado earnings missed by $0.12, revenue fell short of estimates